| Trial ID: | L4269 |
| Source ID: | NCT01508858
|
| Associated Drug: |
Liraglutide
|
| Title: |
Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: liraglutide|DRUG: placebo|DRUG: levonorgestrel / ethinylestradiol
|
| Outcome Measures: |
Primary: AUC of ethinylestradiol|AUC of levonorgestrel | Secondary: AUC (0-t)|Cmax, maximum concentration|tmax, time to reach Cmax|t½, terminal half-life|Adverse events
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
21
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-11
|
| Completion Date: |
2007-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-24
|
| Locations: |
Novo Nordisk Investigational Site, Uppsala, 75323, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01508858
|
